 |
|
|
|
|
|
BSc | FFPM
FRCP | MD(Lond)
DipPharmMedRCP
CBiol | FIBiol |
|
Anthony “Tony” W. Fox is a pharmaceutical physician with more than
20 years in the industry. Previous industrial positions have been at Procter
and Gamble, Glaxo Inc. (Imitrex (R), Ultiva(R), Amerge(R)), and with small
companies. Formerly, Tony Fox was President of the whole of EBD Group,
and continues now as President of EBD Consulting Inc., (Carlsbad, CA,
and Munich, Germany). Among his current professional affiliations are the
American College of Clinical Pharmacology, the American Society of
Pharmacology and Experimental Therapeutics, and the Society of
Apothecaries of London. He is a Fellow of the Institute of Biology and the
Royal College of Physicians, as well as of the latter’s Faculty of
Pharmaceutical Medicine. His numerous publications span industrial,
pharmacological, regulatory, and experimental medicine areas.
|
|
|
|
|
|
FGK Representative
Service GmbH
Heimeranstrasse 35
80339 Munich
Germany
T | +49 (0) 89 893 119-22
F | +49 (0) 89 893 119-20
www.fgk-rs.com
info@fgk-rs.com |
|
|
|
